Furthermore, researchers from the United States reported that patients with hormone receptor-negative breast cancer had lower survival rates than patients with hormone receptor-positive subtypes [13], and the associations between SES and both breast cancer incidence [11] and survival [13] vary by tumor subtype, with a significant association for hormone receptor-positive but not for receptor-negative tumors [13]. The gene discussed is NR4A1; the disease is neoplasm.